N-Acetylcysteine (NAC) Treatment
Sponsors
Medical University of South Carolina, Lahore General Hospital, University Hospital, Lille, Kurdistan University of Medical Sciences, Fudan University
Conditions
Acute InfectionAcute Liver FailureAddictionAlcohol AbuseAlcoholic HepatitisBreast CancerDrug-Induced Liver InjuryParkinson's Disease (PD)
Phase 2
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
CompletedNCT02966873
Start: 2016-10-01End: 2022-09-19Updated: 2026-04-13
Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study
CompletedNCT07093944
Start: 2018-04-09End: 2021-12-22Updated: 2025-07-30
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
RecruitingNCT07117630
Start: 2025-09-25End: 2027-08-01Target: 40Updated: 2026-05-19
N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy
Active, not recruitingNCT07279610
Start: 2024-05-01End: 2026-12-31Target: 44Updated: 2025-12-12
Phase 3
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
Not yet recruitingNCT06956482
Start: 2026-05-01End: 2030-05-01Target: 477Updated: 2026-05-12
A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery
Not yet recruitingNCT07136987
Start: 2026-01-31End: 2031-07-31Target: 1104Updated: 2025-08-22